Junhao Huang1, Jiuquan Zhang1, Huanhuan Ren1, Daihong Liu1, Jing Zhang1, Hong Yu1, Yong Tan1, and Lisha Nie2
1Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, China, 2GE HealthCare MR Research, Beijing, China
Synopsis
Keywords: Synthetic MR, Quantitative Imaging, nasopharyngeal carcinoma
Motivation: In nasopharyngeal carcinoma (NPC) patients, there is a significant variation in tumor response to induction chemotherapy (ICT), which directly impacts prognosis. To address this issue, we aimed to explore a novel imaging biomarker based on pre-treatment synthetic MRI to predict which patients would benefit the most from the additional ICT.
Goal(s): Evaluating the value of pre-treatment synthetic MRI quantitative parameter map histogram characteristics in predicting the efficacy of ICT for NPC.
Approach: 40 NPC patients were prospectively enrolled, and each was imaged with synthetic MRI.
Results: T2_Minimun and T2_RootMeanSquared show promise as imaging markers for predicting the response to ICT in NPC.
Impact: The utilization of synthetic MRI may
serve as an effective diagnostic tool for evaluating the response to ICT in
clinical practice. Identifying patients who are unlikely to respond to ICT
early on, can help offer
them alternative treatment options.
Introduction
Induction chemotherapy (ICT) followed by
concurrent chemoradiotherapy (CCRT) or CCRT alone are both now recommended for
locoregionally advanced nasopharyngeal carcinoma (NPC) in 2023 CACA guideline1. While ICT+CCRT has shown improved patient
prognosis, it is associated with high toxicity and side effects2-4. Additionally, a significant portion of
patients (10%) exhibit a poor response to treatment, resulting in NPC treatment
failure5. Therefore, predicting the patient's
response to ICT before treatment and adjusting the treatment plan can avoid
unnecessary treatment and side effects.
Synthetic MRI (SyMRI) is a cutting-edge
technique capable of generating T1, T2, and PD maps, as well as synthesizing
multiple contrast-weighted images, all within a clinically feasible time frame6. Moreover, histogram
analysis can provide multiple parameters reflecting tumor heterogeneity and
changes in the tumor microenvironment. Recent studies have successfully applied histogram
analysis of SyMRI to investigate prognostic factors in breast cancer,
nasopharyngeal cancer, and rectal cancer7-9. However, no research has yet examined the
therapeutic effect of NPC using this approach.
Therefore, the purpose of our study is to investigate the
predictive value of histogram characteristics derived from quantitative
parameters obtained through SyMRI in NPC patients after ICT.Materials and Methods
This prospective
study was approved by the Ethics Committee of our hospital, and informed
consent was obtained from all patients before MRI examination.
Patients
40 NPC patients were prospectively
enrolled. The Response Evaluation Criteria in Solid Tumors (RECIST1.1) guidelines
were used to evaluate the efficacy: patients with partial response (PR) and complete
response (CR) were defined as effective group, and stable disease (SD) was
defined as ineffective group.
MRI Acquisition
MRI was performed using a 3T scanner (SIGNATM
Premier, GE Healthcare) with a 48-channel head and neck unite coil.
SyMRI, the parameters were as follows: TR, 4000 ms; TE, 16.0/89.4 ms; slice
thickness/ gap, 3.0/0mm; FOV, 180 mm; acquisition matrix, 192 × 192; NEX, 1; acquisition
time, 4 min 32 s.
Data Analysis
The acquired raw images were processed
using SyMRI software (version 8.0, Synthetic MR) to generate
three quantitative maps (T1 map, T2 map, and PD map). ITK-SNAP
software is used to outline volumes of interest (VOIs), 3D Slicer software to
extract histogram features.
Data Analysis
All statistical analyses were performed
using SPSS 26.0 software and MedCalc 19.8. The Kolmogorov–Smirnov test was
adopted to assess whether the continuous variable was normally distributed. the
histogram parameters were compared between two groups using Student’s t test or
Mann–Whitney U test. Then, parameters with statistically significant
differences were included in multivariate logistic regression analysis. the
receiver operating characteristic (ROC) curve was generated based on the
significant features, and the area under the curve (AUC), sensitivity, and
specificity were reported.Results
Table 1 showed
that there were significant differences in T2_Mean, T2_Median, T2_Minimum,
T2_RootMeanSquared and PD_Mean between the effective and the ineffective group
(P< 0.05). Multivariate analysis demonstrated that
T2_Minimum(P=0.032) and T2_RootMeanSquared(P=0.046) were the independent
prediction factor for predicting the response to ICT in NPC (Table 2). Clinical
examples are provided in Figure 1.
The ROC analysis showed the AUC of
T2_RootMeanSquared (AUC = 0.689) was slightly lower than that of T2_Minimum
(AUC 0.849, P= 0.118), the AUC of T2_Minimum (AUC = 0.849) was slightly lower
than that of combined (AUC 0.929, P= 0.167). Combined demonstrated the optimal
performance with AUC of 0.929, which was significantly higher than T2_Minimum
(AUC = 0.849, P= 0.01) (Table 3, Figure2)Discussion and Conclusion
ICT plays a
crucial role in the treatment of patients with locally advanced NPC, as the
response to ICT is closely associated with long-term prognosis. Our study
revealed that T2_Minimun and T2_RootMeanSquared are independent predictors of
the effectiveness of ICT for NPC, and the model of T2_Minimun and combined
parameters has high predictive efficiency.
T2 relaxation
time, a tissue-specific magnetic resonance parameter, was found to be
informative in our analysis. We observed significantly lower histogram
parameters derived from the T2 map in the ineffective group compared to the
effective group. Tumors with lower T2 values usually have a higher cellular
density, lymphocyte/plasma cell infiltration, and necrotic materials in the
intercellular space, which might cause reduced extracellular space and free
water content in tissue, resulting in shorter T2 values10. Many previous
studies have found that high-grade tumors have lower T2 values than low-grade
tumors and are more heterogeneous11,12. We speculate
that intra-tumor heterogeneity may contribute to differences in efficacy.
In summary, the histogram parameters
derived from baseline syMRI were found to be promising imaging markers for
predicting the response to ICT in NPC. This suggests that syMRI could serve as
a valuable diagnostic tool for evaluating ICT response in clinical practice.Acknowledgements
No acknowledgement found.References
1. Tang L-L, Chen L, Hu C-S, Yi J-L, Li
J-G, He X, Jin F, Zhu X-D, Chen X-Z, Sun Y
et al: CACA guidelines for holistic
integrative management of nasopharyngeal carcinoma. Holistic Integrative Oncology 2023, 2(1).
2. Sun Y, Li W-F, Chen
N-Y, Zhang N, Hu G-Q, Xie F-Y, Sun Y, Chen X-Z, Li J-G, Zhu X-D et al: Induction chemotherapy plus concurrent chemoradiotherapy versus
concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal
carcinoma: a phase3, multicentre, randomised controlled trial. The Lancet Oncology 2016, 17(11):1509-1520.
3. Chen Y-P, Tang L-L,
Yang Q, Poh S-S, Hui EP, Chan ATC, Ong W-S, Tan T, Wee J, Li W-F et al: Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic
Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four
Randomized Trials. Clinical Cancer
Research 2018, 24(8):1824-1833.
4. Zhang Y, Chen L, Hu
G-Q, Zhang N, Zhu X-D, Yang K-Y, Jin F, Shi M, Chen Y-P, Hu W-H et al: Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal
Carcinoma. New England Journal of
Medicine 2019, 381(12):1124-1135.
5. Peng H, Chen L, Li
WF, Guo R, Mao YP, Zhang Y, Guo Y, Sun Y, Ma J: Tumor response to neoadjuvant chemotherapy predicts long‐term survival outcomes in
patients with locoregionally advanced nasopharyngeal carcinoma: A secondary
analysis of a randomized phase 3 clinical trial. Cancer 2016, 123(9):1643-1652.
6. Warntjes JBM,
Dahlqvist O, Lundberg P: Novel method
for rapid, simultaneous T1, T*2, and proton density quantification. Magnetic Resonance in Medicine 2007, 57(3):528-537.
7. Lian S, Liu H, Meng
T, Ma L, Zeng W, Xie C: Quantitative
synthetic MRI for predicting locally advanced rectal cancer response to
neoadjuvant chemoradiotherapy. European
Radiology 2022, 33(3):1737-1745.
8. Yang F, Li X, Li Y,
Lei H, Du Q, Yu X, Li L, Zhao Y, Xie L, Lin M: Histogram analysis of quantitative parameters from synthetic MRI:
correlations with prognostic factors in nasopharyngeal carcinoma. European Radiology 2023, 33(8):5344-5354.
9. Zhao R, Du S, Gao S,
Shi J, Zhang L: Time Course Changes of
Synthetic Relaxation Time During Neoadjuvant Chemotherapy in Breast Cancer: The
Optimal Parameter for Treatment Response Evaluation. Journal of Magnetic Resonance Imaging 2023, 58(4):1290-1302.
10. Gao W, Zhang S, Guo
J, Wei X, Li X, Diao Y, Huang W, Yao Y, Shang A, Zhang Y et al: Investigation of
Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign
and Malignant Breast Lesions as Compared to BI‐RADS. Journal of Magnetic Resonance Imaging 2020,
53(4):1118-1127.
11. Cui Y, Han S, Liu M,
Wu Py, Zhang W, Zhang J, Li C, Chen M: Diagnosis
and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI. Journal of Magnetic Resonance Imaging 2020,
52(2):552-564.
12. Cai Q, Wen Z, Huang
Y, Li M, Ouyang L, Ling J, Qian L, Guo Y, Wang H: Investigation of Synthetic Magnetic Resonance Imaging Applied in the
Evaluation of the Tumor Grade of Bladder Cancer. Journal of Magnetic Resonance Imaging 2021, 54(6):1989-1997.